Universitätsklinikum Greifswald

Universitätsklinikum Greifswald, also known as Universitätsmedizin Greifswald (UMG), is a premier academic medical institution in northeastern Germany that integrates advanced patient care with high-impact biomedical research. The center is globally recognized for its leadership in community medicine, particularly through the long-term Study of Health in Pomerania (SHIP), which provides extensive epidemiological data for disease prevention and population health. UMG is also a pioneer in the field of plasma medicine, collaborating with the Leibniz Institute for Plasma Science and Technology to develop innovative cold physical plasma therapies for wound healing and oncology. With over 40 specialized clinics and institutes, the facility serves as a major hub for international clinical trials across therapeutic areas such as cardiology, neurology, and immunology. The institution maintains a strong focus on molecular medicine and operates state-of-the-art facilities for biobanking and GMP-certified cell therapy production.